<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163106">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01880996</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-13-0112-DG-CTIL</org_study_id>
    <nct_id>NCT01880996</nct_id>
  </id_info>
  <brief_title>Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies</brief_title>
  <official_title>The Effect of Tai-chi/Qi-gong on Quality of Life (QOL), Sleep, and Fatigue in Patients With Gynecological Malignancies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tel Aviv University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <authority>Israel: Israeli Health Ministry Pharmaceutical Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Oncologic patients often report increased fatigue during and after chemotherapy. Evidence
      suggests Tai-chi/Qi-gong may improve quality of life (QOL) in oncologic patients treated
      with chemotherapy. Previous studies, mostly performed in a population of breast cancer
      patients, have demonstrated the benefits of  Tai-chi/Qi-gong practice in improving quality
      of life (1), reducing bone resorption (2), preventing the decrease of blood counts (WBC and
      Hb) (3), and reducing inflammation (4).

      The aim of this pilot study is to evaluate the effect of Tai-chi/Qi-gong on QOL, sleep, and
      fatigue in patients with gynecological malignancies, particularly in patients with ovarian
      cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tai-chi/Qi-gong is a complementary medicine technique that synergizes the mind-body
      connection. The technique employs a series of positions and movements that are performed in
      a slow, flowing manner to help a person concentrate on breathing and motion.

      The effect of Tai-chi/Qi-gong on fatigue, quality of life, and quality of sleep will be
      assessed in gynecological cancer patients. This trial will recruit 60 patients with
      gynecological malignancies, who receive first or second line chemotherapy. The patients will
      be allocated according to their preference to either the study or the control group. The
      Tai-chi/Qi-gong classes will take place once a week, for 10 consecutive weeks, at the
      facilities of the gyneco-oncology department.   All patients will fill out the
      questionnaires at the beginning of the study, after 5 weeks, and upon the completion of the
      study (10 weeks).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in the Multidimensional Quality of Life Scale cancer MQOLS-CA</measure>
    <time_frame>Week 0, Week 5, Week 10</time_frame>
    <safety_issue>No</safety_issue>
    <description>The Multidimensional Quality of Life Scale cancer MQOLS-CA was written by Padilla (5) and translated into Hebrew by Dorit Pud (6).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the Lee Fatigue Scale (LFS)</measure>
    <time_frame>Week 0, Week 5, Week 10</time_frame>
    <safety_issue>No</safety_issue>
    <description>The Lee Fatigue Scale (LFS). The questionnaire was compiled by Lee (7) and translated into Hebrew by Dr. Dorit Pud (6).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Visual Analog Scale for Pain</measure>
    <time_frame>Week 0, Week 5, Week 10</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in the White Blood Cell Count</measure>
    <time_frame>Week 0, Week 3, Week 6, Week 9</time_frame>
    <safety_issue>No</safety_issue>
    <description>Results of the routine blood exams will be documented</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in the Hemoglobin in blood</measure>
    <time_frame>Week 0, Week 3, Week 6, Week 9</time_frame>
    <safety_issue>No</safety_issue>
    <description>Results of the routine blood exams will be documented</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in the C-reactive protein in blood</measure>
    <time_frame>Week 0, Week 3, Week 6, Week 9</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Change in the Body Weight</measure>
    <time_frame>Week 0, Week 5, Week 10</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Change in the number of Emergency Room visits</measure>
    <time_frame>Week 0, Week 5, Week 10</time_frame>
    <safety_issue>No</safety_issue>
    <description>Emergency Room visits for nausea, vomiting, or dehydration</description>
  </other_outcome>
  <other_outcome>
    <measure>Pattern of use of Complementary Medicine</measure>
    <time_frame>Week 0, Week 5, Week 10</time_frame>
    <safety_issue>No</safety_issue>
    <description>List of Complementary modalities used including Medical Cannabis</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ovarian Cancer</condition>
  <condition>Primary Peritoneal Cancer</condition>
  <condition>Other Gynecological Cancers</condition>
  <arm_group>
    <arm_group_label>Tai-chi/Qi-gong</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 gynecological cancer patients scheduled for the first or second line of  chemotherapy treatment will be recruited for this study to receive Tai-chi/qigong treatment initiated at the beginning of chemotherapy therapy, once a week (45 min each), for 10 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>30 gynecological cancer patients scheduled for primary or secondary chemotherapy treatment, will be evaluated by the same measures as the intervention group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Tai-chi/Qi-gong</intervention_name>
    <description>Tai-chi/Qi-gong employs a series of positions and movements that are performed in a slow, flowing manner to help a person concentrate on breathing and motion. The treatments will take place once a week at the Dept. of the Gyneco-oncology and the patients will be instructed to practice tai-chi at home on a daily basis</description>
    <arm_group_label>Tai-chi/Qi-gong</arm_group_label>
    <other_name>Tai Chi</other_name>
    <other_name>Qi-gong</other_name>
    <other_name>Taichi</other_name>
    <other_name>Qigong</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with gynecological malignancies undergoing primary or secondary chemotherapy

        Exclusion Criteria:

          -  Motor disability;

          -  Less than 1 month since the last abdominal surgery;

          -  Ascites
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dorit Gamus, M.D. Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dorit Gamus, M.D. Ph.D.</last_name>
    <phone>97235303956</phone>
    <email>dorit.gamus@sheba.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sheba Hospital</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dorit Gamus, M.D. Ph.D.</last_name>
      <phone>9725303956</phone>
      <email>dorit.gamus@sheba.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Jacob Korach, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Limor Helpman, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mario Binder, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ludmila Yermin, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tamar Perl, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nisim Tamira, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shalom Firster, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilad Ben-Baruch, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aliza Hakimian, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dorit Gamus, M.D. Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Oh B, Butow P, Mullan B, Clarke S, Beale P, Pavlakis N, Kothe E, Lam L, Rosenthal D. Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Ann Oncol. 2010 Mar;21(3):608-14. doi: 10.1093/annonc/mdp479. Epub 2009 Oct 30.</citation>
    <PMID>19880433</PMID>
  </reference>
  <reference>
    <citation>Yeh ML, Lee TI, Chen HH, Chao TY. The influences of Chan-Chuang qi-gong therapy on complete blood cell counts in breast cancer patients treated with chemotherapy. Cancer Nurs. 2006 Mar-Apr;29(2):149-55.</citation>
    <PMID>16565626</PMID>
  </reference>
  <reference>
    <citation>Padilla GV, Mishel MH, Grant MM. Uncertainty, appraisal and quality of life. Qual Life Res. 1992 Jun;1(3):155-65.</citation>
    <PMID>1301125</PMID>
  </reference>
  <reference>
    <citation>Pud D, Ben Ami S, Cooper BA, Aouizerat BE, Cohen D, Radiano R, Naveh P, Nikkhou-Abeles R, Hagbi V, Kachta O, Yaffe A, Miaskowski C. The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes. J Pain Symptom Manage. 2008 Feb;35(2):162-70. Epub 2007 Dec 21. PubMed PMID: 18082357.</citation>
    <PMID>18082357</PMID>
  </reference>
  <reference>
    <citation>Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res. 1991 Mar;36(3):291-8.</citation>
    <PMID>2062970</PMID>
  </reference>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 20, 2013</lastchanged_date>
  <firstreceived_date>May 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Dorit Gamus</investigator_full_name>
    <investigator_title>Director, Complementary Medicine Service</investigator_title>
  </responsible_party>
  <keyword>Ovarian Cancer</keyword>
  <keyword>Gynecological Malignancies</keyword>
  <keyword>Chemotherapy</keyword>
  <keyword>Tai-chi</keyword>
  <keyword>Qigong</keyword>
  <keyword>Fatigue</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Sleep disturbance</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Peritoneal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
